Authors:
Schneider, R
Agol, VI
Andino, R
Bayard, F
Cavener, DR
Chappell, SA
Chen, JJ
Darlix, JLE
Dasgupta, A
Donze, O
Duncan, R
Elroy-Stein, O
Farabaugh, PJ
Filipowicz, W
Gale, M
Gehrke, L
Goldman, E
Groner, Y
Harford, JB
Hatzoglou, M
He, B
Hellen, CUT
Hentze, MW
Hershey, J
Hershey, P
Hohn, T
Holcik, M
Hunter, CP
Igarashi, K
Jackson, R
Jagus, R
Jefferson, LS
Joshi, B
Kaempfer, R
Katze, MG
Kaufman, RJ
Kiledjian, M
Kimball, SR
Kimchi, A
Kirkegaard, K
Koromilas, AE
Krug, RM
Kruys, V
Lamphear, BJ
Lemon, S
Lloyd, RE
Maquat, LE
Martinez-Salas, E
Mathews, MB
Mauro, VP
Miyamoto, S
Mohr, I
Morris, DR
Moss, EG
Nakashima, N
Palmenberg, A
Parkin, NT
Pe'ery, T
Pelletier, J
Peltz, S
Pestova, TV
Pilipenko, EV
Prats, AC
Racaniello, V
Read, GS
Rhoads, RE
Richter, JD
Rivera-Pomar, R
Rouault, T
Sachs, A
Sarnow, P
Scheper, GC
Schiff, L
Schoenberg, DR
Semler, BL
Siddiqui, A
Skern, T
Sonenberg, N
Sossin, W
Standart, N
Tahara, SM
Thomas, AAM
Toulme, JJ
Wilusz, J
Wimmer, E
Witherell, G
Wormington, M
Citation: R. Schneider et al., New ways of initiating translation in eukaryotes?, MOL CELL B, 21(23), 2001, pp. 8238-8241
Citation: G. Arad et al., Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation, NAT MED, 6(4), 2000, pp. 414-421
Authors:
Ben-Asouli, Y
Banai, Y
Hauser, H
Kaempfer, R
Citation: Y. Ben-asouli et al., Recognition of 5 '-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2, NUCL ACID R, 28(4), 2000, pp. 1011-1018
Authors:
Osman, F
Jarrous, N
Ben-Asouli, Y
Kaempfer, R
Citation: F. Osman et al., A cis-acting element in the 3 '-untranslated region of human TNF-alpha mRNA renders splicing dependent on the activation of protein kinase PKR, GENE DEV, 13(24), 1999, pp. 3280-3293
Citation: M. Ketzinel et R. Kaempfer, Cell-mediated suppression of human interleukin-2 gene expression at splicing of mRNA, IMMUNOL LET, 68(1), 1999, pp. 161-166